Physician profile
Ashley Llera
NPI 1780184853
$2,536.75
in general payments reported to CMS, 2019-2025
18 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $558 · 2022: $470 · 2023: $472 · 2024: $595 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,508.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $650.59 | 2021-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $432.69 | 2022-2024 | Tremfya, Simponi, Stelara |
| Allergan, INC. | $260.15 | 2021-2022 | |
| Genzyme Corporation | $252.87 | 2021-2024 | |
| Pfizer INC. | $215.36 | 2021-2023 | |
| Abbvie INC. | $177.03 | 2023-2025 | |
| Janssen Scientific Affairs, LLC | $123.46 | 2022 | |
| Ucb, INC. | $108.41 | 2024-2025 | Bimzelx |
| Lilly USA, LLC | $80.47 | 2023-2025 | Ebglyss, Taltz |
| Vyne Pharmaceuticals INC. | $35.20 | 2021 | |
| Sun Pharmaceutical Industries INC. | $32.40 | 2023 | Winlevi, Absorica Ld |
| Mayne Pharma Commercial LLC | $32.35 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.50 | 2025 | Spevigo |
| Nabriva Therapeutics, Plc | $24.02 | 2022 | |
| Amgen INC. | $23.17 | 2023 | Otezla |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $22.93 | 2021 | |
| Botanix Sb INC | $20.55 | 2025 | Sofdra |
| Leo Pharma INC. | $17.60 | 2024 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Llera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.